Amplite® Fluorimetric Fluorescamine Protein Quantitation Kit *Blue Fluorescence*
Ordering information
Price | |
Catalog Number | |
Unit Size | |
Quantity |
Additional ordering information
Telephone | 1-800-990-8053 |
Fax | 1-800-609-2943 |
sales@aatbio.com | |
Quotation | Request |
International | See distributors |
Shipping | Standard overnight for United States, inquire for international |
Storage, safety and handling
H-phrase | H303, H313, H333 |
Hazard symbol | XN |
Intended use | Research Use Only (RUO) |
R-phrase | R20, R21, R22 |
UNSPSC | 12171501 |
Overview | ![]() ![]() |
See also: Amplite® Reagents and Assay Kits
Fluorescamine is intrinsically non-fluorescent but reacts rapidly with primary aliphatic amines, including those in peptides and proteins, to yield a blue-green-fluorescent derivative. The Amplite® fluorescamine protein assay kit provides a simple method for quantifying protein concentration in solutions. This Amplite® fluorescamine protein assay kit can be performed in a convenient 96-well or 384-well microtiter-plate format and easily adapted to automation with no separation steps required. The assay can be completed within 30 minutes. With the Amplite® fluorescamine protein assay kit, as little as 3 ug/mL of BSA can be detected.
Platform
Fluorescence microplate reader
Excitation | 380 |
Emission | 470 |
Cutoff | 420 |
Recommended plate | Solid black |
Components
Example protocol
AT A GLANCE
Protocol summary
- Prepare fluorescamine working solution (25 µL)
- Add BSA standards or test samples (75 µL)
- Incubate at room temperature for 5 - 30 minutes
- Read fluorescence intensity at Ex/Em = 380/470 nm
Important notes
Thaw all the kit components at room temperature before starting the experiment.
PREPARATION OF STANDARD SOLUTION
BSA standard
For convenience, use the Serial Dilution Planner: https://www.aatbio.com/tools/serial-dilution/11100
For convenience, use the Serial Dilution Planner: https://www.aatbio.com/tools/serial-dilution/11100
Dilute the appropriate amount of BSA Standard 1 mg/mL (Component C) into PBS by performing 1:2 serial dilutions to get serial dilutions of BSA standard (BS7 - BS1).
PREPARATION OF WORKING SOLUTION
Add the whole content of DMSO (Component B) into the bottle of Fluorescamine (Component A), and mix well. Note: 2.5 mL of fluorescamine working solution is enough for 1 plate.
SAMPLE EXPERIMENTAL PROTOCOL
Table 1. Layout of BSA standards and test samples in a solid black 96-well microplate. BS= BSA Standards (BS1 - BS7, 1.563 to 100 µg/mL), BL=Blank Control, TS=Test Samples.
BL | BL | TS | TS |
BS1 | BS1 | ... | ... |
BS2 | BS2 | ... | ... |
BS3 | BS3 | ||
BS4 | BS4 | ||
BS5 | BS5 | ||
BS6 | BS6 | ||
BS7 | BS7 |
Table 2. Reagent composition for each well.
Well | Volume | Reagent |
BS1 - BS7 | 75 uL | Serial Dilution (1.563 to 100 ug/mL) |
BL | 75 uL | PBS |
TS | 75 uL | Test Sample |
- Prepare BSA standards (BS), blank controls (BL), and test samples (TS) according to the layout provided in Tables 1 and 2. For a 384-well plate, use 30 µL of reagent per well instead of 75 µL.
- Add 25 µL of fluorescamine working solution to each well of BSA standard, blank control, and test samples to make the total assay volume of 100 µL/well. For a 384-well plate, add 10 µL of fluorescamine working solution into each well instead, for a total volume of 40 µL/well.
- Incubate the reaction at room temperature for 5 to 30 minutes, protected from light.
- Monitor the fluorescence increase with a fluorescence plate reader at Ex/Em = 380/470 nm.
Images
Citations
View all 1 citations: Citation Explorer
Covalent vaccination with Trypanosoma cruzi Tc24 induces catalytic antibody production
Authors: Gunter, Sarah M and Versteeg, Leroy and Jones, Kathryn M and Brian, Keegan P and Strych, Ulrich and Bottazzi, Maria Elena and Hotez, Peter J and Brown, Eric L
Journal: Parasite immunology (2018): e12585
Authors: Gunter, Sarah M and Versteeg, Leroy and Jones, Kathryn M and Brian, Keegan P and Strych, Ulrich and Bottazzi, Maria Elena and Hotez, Peter J and Brown, Eric L
Journal: Parasite immunology (2018): e12585
References
View all 41 references: Citation Explorer
Fluorescence of aromatic amines and their fluorescamine derivatives for detection of explosive vapors
Authors: Eastwood D, Fern and ez C, Yoon BY, Sheaff CN, Wai CM.
Journal: Appl Spectrosc (2006): 958
Authors: Eastwood D, Fern and ez C, Yoon BY, Sheaff CN, Wai CM.
Journal: Appl Spectrosc (2006): 958
Fluorimetric determination of histamine in fish using micellar media and fluorescamine as labelling reagent
Authors: Adamou R, Coly A, Douabale SE, Saleck ML, Gaye-Seye MD, Tine A.
Journal: J Fluoresc (2005): 679
Authors: Adamou R, Coly A, Douabale SE, Saleck ML, Gaye-Seye MD, Tine A.
Journal: J Fluoresc (2005): 679
Determination of 4-amino-m-cresol and 5-amino-o-cresol by high performance liquid chromatography and fluorescence derivatization using fluorescamine
Authors: Eggenreich K, Zach E, Beck H, Wintersteiger R.
Journal: J Biochem Biophys Methods (2004): 35
Authors: Eggenreich K, Zach E, Beck H, Wintersteiger R.
Journal: J Biochem Biophys Methods (2004): 35
Chiral separation of fluorescamine-labeled amino acids using microfabricated capillary electrophoresis devices for extraterrestrial exploration
Authors: Skelley AM, Mathies RA.
Journal: J Chromatogr A (2003): 191
Authors: Skelley AM, Mathies RA.
Journal: J Chromatogr A (2003): 191
LC determination of aminoglutethimide enantiomers as dansyl and fluorescamine derivatives in tablet formulations
Authors: Cesur N, Apak TI, Aboul-Enein HY, Ozkirimli S.
Journal: J Pharm Biomed Anal (2002): 487
Authors: Cesur N, Apak TI, Aboul-Enein HY, Ozkirimli S.
Journal: J Pharm Biomed Anal (2002): 487
Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine
Authors: Belal F, Abdine H, Al-Majed A, Khalil NY.
Journal: J Pharm Biomed Anal (2002): 253
Authors: Belal F, Abdine H, Al-Majed A, Khalil NY.
Journal: J Pharm Biomed Anal (2002): 253
A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids
Authors: Bantan-Polak T, Kassai M, Grant KB.
Journal: Anal Biochem (2001): 128
Authors: Bantan-Polak T, Kassai M, Grant KB.
Journal: Anal Biochem (2001): 128
Detection, quantitation, and identification of residual aminopenicillins by high-performance liquid chromatography after fluorescamine derivation
Authors: Hong C, Kondo F.
Journal: J Food Prot (2000): 1421
Authors: Hong C, Kondo F.
Journal: J Food Prot (2000): 1421
Determination of taurine in plasma by capillary zone electrophoresis following derivatisation with fluorescamine
Authors: Kelly MT, Fabre H, Perrett D.
Journal: Electrophoresis (2000): 699
Authors: Kelly MT, Fabre H, Perrett D.
Journal: Electrophoresis (2000): 699
Characterisation of the binding interaction between poly(L-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors
Authors: Read ML, Etrych T, Ulbrich K, Seymour LW.
Journal: FEBS Lett (1999): 96
Authors: Read ML, Etrych T, Ulbrich K, Seymour LW.
Journal: FEBS Lett (1999): 96
Application notes
A Library of Well-Defined and Water-Soluble Poly(alkyl phosphonate)s with Adjustable Hydrolysis
Acetylcholinesterase Inhibitory Activity of Pigment Echinochrome A
Ameliorative Effect of Novel Vitamin Formula with Herbal Extracts on Scopolamine-Induced Alzheimer's Disease
An Increase in Plasma Homovanillic Acid with Cocoa Extract Consumption Is Associated with the Alleviation of Depressive Symptoms in Overweight or Obese Adults
Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity
Acetylcholinesterase Inhibitory Activity of Pigment Echinochrome A
Ameliorative Effect of Novel Vitamin Formula with Herbal Extracts on Scopolamine-Induced Alzheimer's Disease
An Increase in Plasma Homovanillic Acid with Cocoa Extract Consumption Is Associated with the Alleviation of Depressive Symptoms in Overweight or Obese Adults
Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity